|
Catalog Number 1161935 |
Device Problem
Patient-Device Incompatibility (2682)
|
Patient Problems
Abscess (1690); Bacterial Infection (1735)
|
Event Date 12/14/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
As reported, post implant of the xenmatrix graft and bowel resection procedure, the patient was diagnosed with a surgical site infection and abscess.The clinician has assessed the patient¿s postoperative course of surgical site infection and abscess as possibly related to the study device and possibly related to the procedure.However, based on the information provided, no conclusion can be made.Review of manufacturing records confirms product was manufactured to specification.To date, this is the only reported complaint for this manufacturing lot of 16 units released for distribution in (b)(6) 2015.Infection is an known inherent risk of surgery and is listed as a possible complications in the instructions-for-use (ifu) supplied with the device.In regards to infection, the warnings section of the ifu states, "if an infection develops, it should be treated aggressively.".
|
|
Event Description
|
Alleged per clinical trial dvl-he-020: on (b)(6) 2015, the subject patient underwent first time recurrent midline incisional open hernia repair procedure, during which a xenmatrix surgical graft was trimmed and placed in underlay fashion intra-peritoneally, fixated using maxon sutures with interrupted stitch technique.The fascia closure was achieved using vicryl sutures with interrupted stitch technique and full skin closure was achieved using sutures.The patient was discharged on (b)(6) 2015.Concomitant procedure includes lysis of adhesion(s) and bowel resection.On (b)(6) 2015, the subject patient was diagnosed with surgical site infection and abscess.The patient underwent drainage culture test, resulted in positive for methicillin-resistant staphylococcus aureus.The patient was hospitalized and underwent drain insertion using interventional radiology, and treated with oral antibiotics.The patient was discharged to home on (b)(6) 2015 and the ae was resolved on (b)(6) 2016.On (b)(6) 2016, the subject patient was diagnosed with surgical site infection and abscess.The patient underwent drainage culture test, which resulted in no identification of pathogens.The patient was hospitalized on 09-feb-2016 and underwent drain insertion using interventional radiology, and treated with oral antibiotics.The patient was discharged to home on (b)(6) 2016 and the ae was resolved on (b)(6) 2016.The ae is clinically assessed to be of mild severity, possibly related to the study device and possibly related to the procedure and recovered/resolved.The reported adverse meets the definition of an sae (serious adverse event) and does not meet uade (unlisted adverse device event).
|
|
Search Alerts/Recalls
|
|
|